Torrent Pharma’s rise was largely authored by Shri U.N. Mehta, who blazed a new trail in the Indian pharmaceutical industry by implementing successfully the concept of niche marketing. Shri U.N. Mehta, aided later on by his two sons, Shri Sudhir Mehta and Shri Samir Mehta, carved out from scratch, the Torrent business empire. The cornerstones which built it - gritty determination, bold vision and strategic depth, still remain.

The Torrent Group's interests in pharma are represented by its flagship concern, Torrent Pharmaceuticals Limited (TPL). Torrent Pharma’s business is poised to expand, across the country as well as beyond its shores. This is because of emerging realities that present a vastly different scenario of global competition, one that Torrent is well-equipped to respond to and profit from.